Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.320
-0.120 (-4.92%)
At close: Apr 1, 2025, 4:00 PM
2.402
+0.082 (3.55%)
After-hours: Apr 1, 2025, 4:41 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $16.09 million as of April 1, 2025. Its market cap has increased by 16.61% in one year.
Market Cap
16.09M
Enterprise Value
15.36M
1-Year Change
16.61%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since November 5, 2015, Edesa Biotech's market cap has decreased from $74.90M to $16.09M, a decrease of -78.51%. That is a compound annual growth rate of -15.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 16.90M | 191.38% |
| Dec 31, 2024 | 5.80M | -60.00% |
| Dec 29, 2023 | 14.50M | -65.31% |
| Dec 30, 2022 | 41.80M | -45.07% |
| Dec 31, 2021 | 76.10M | 70.25% |
| Dec 31, 2020 | 44.70M | 45.13% |
| Dec 31, 2019 | 30.80M | 528.57% |
| Dec 31, 2018 | 4.90M | -42.35% |
| Dec 29, 2017 | 8.50M | -58.74% |
| Dec 30, 2016 | 20.60M | -62.34% |
| Dec 31, 2015 | 54.70M | -26.97% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.86B |
| UnitedHealth Group | 480.76B |
| Johnson & Johnson | 399.87B |
| AbbVie | 370.11B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.87B |
| Merck & Co. | 226.94B |
| AstraZeneca | 225.46B |